The European health record promises that a doctor in another European Union country will be able to see essential information about a patient in their care, without the patient having to carry a stack of paper test results. It also raises sensitive questions: who will be able to read your diagnoses, when will data sharing begin, how can you restrict access, and can employers or insurers find out your medical history?
The answer is not that “all doctors will see everything tomorrow”. Regulation (EU) 2025/327 on the European Health Data Space (EHDS) entered into force on 26 March 2025, but the main patient-facing functions will apply in stages, starting on 26 March 2029 and 26 March 2031. Europe is also creating a separate, strictly regulated route through which data may be analysed for research.
For Romanian readers, there is also a new reality in 2026: the National Health Insurance House (CNAS) launched the eHealthaMea portal on 1 September. Using ROeID authentication, people can consult medical and administrative information already available in the national system. The Romanian portal’s launch does not, by itself, demonstrate that every test from every clinic or every EU country is already interoperable. The national electronic health record, the CNAS portal and future EHDS obligations are not the same thing.
European health record: the real timeline, 2025–2035
The European Commission distinguishes between a regulation entering into force and the operational application of rights and obligations. This distinction avoids a common misunderstanding: an adopted regulation that is in force does not mean that every hospital and laboratory can automatically exchange every result across all member states.
| Key date | What takes effect or is being prepared | What should not be claimed |
|---|---|---|
| 26 March 2025 | The EHDS Regulation enters into force; the transition begins | That all records are already accessible across the EU |
| 26 March 2027 | General application of certain governance provisions, and preparation of systems and technical acts | That all prescriptions and tests are transferred automatically across borders |
| 26 March 2029 | Mandatory exchange of patient summaries, prescriptions and dispensing information; most secondary-use categories | That all imaging and laboratory results must already be exchanged |
| 26 March 2031 | Extension to laboratory results and other investigations, imaging and hospital discharge reports; remaining secondary-use categories, including certain genomic data | That any private app receives access without rules |
| 26 March 2035 | Third countries and international organisations may apply to join HealthData@EU, subject to the Regulation’s conditions | That medical databases will be open to the world |
In September 2026, the EU also adopted additional technical rules for MyHealth@EU, including Implementing Regulation (EU) 2026/2083 and the framework for exchanging identification information on professionals and providers in 2026/2099. These acts set out the technical organisation and security of data flows. They do not, on their own, alter the 2029 and 2031 deadlines for priority data categories.
Who can see medical test results: two very different legal routes
The Regulation draws a fundamental distinction between primary use — health data accessed to treat a patient — and secondary use — data reused for research, public health, policymaking and other purposes listed in law. Confusing the two leads to alarmist claims such as “any company will be able to see your medical record”.
| Person or entity | Can they see data? | Essential condition |
|---|---|---|
| The patient | Yes, their own priority electronic health data | Free access through patient-access services, introduced in stages under EHDS |
| A doctor treating the patient | Yes, relevant and necessary data within the limits of their role | A care relationship, professional authentication, national rules and the patient’s restrictions |
| Other professionals not treating the patient | They have no general right to consult any record | They need a legal basis and an authorised professional role |
| A researcher or company conducting research | May use data for permitted purposes through the secondary-use mechanism | An authorisation or approved application, data minimisation, anonymisation/pseudonymisation and a secure environment |
| An employer making a hiring decision | EHDS does not grant access rights | Using data obtained through secondary use for employment discrimination is prohibited |
| An insurer setting individual premiums | It may not use EHDS secondary-use data to disadvantage individuals | Decisions such as excluding someone from a contract or changing premiums based on such data are prohibited |
Important: the fact that an institution may process data to reimburse a consultation or meet an existing legal obligation is not the same as permission to view a full medical summary for its own purposes. The EHDS Regulation does not create unrestricted access for authorities, companies, hospitals, universities or people employed in the health system.
In treatment: what a doctor can see, and why they cannot access every patient’s record
Under the primary-use provisions, health professionals may consult, through dedicated services, the relevant and necessary data of people they are treating, including in cross-border situations. Member states define rights according to a professional’s role and duties. The professional’s identity must be verified electronically, and access takes place through authorised infrastructures.
A doctor in another EU member state may need a patient summary during a consultation or emergency, to see information on allergies, medication and other relevant details. But the doctor does not become the owner of the data and cannot look through the records of all European patients merely because they hold a professional account.
The term “European health record” can also lead to another misconception: EHDS does not mean that every medical file is uploaded to a single, public, centralised EU database. MyHealth@EU connects national systems and national contact points for standardised, secure exchanges. Institutions and national systems retain their own obligations for record-keeping and data protection.
Can you hide certain test results? Yes, but it may affect care
Article 8 of the Regulation provides for a person’s right to restrict access to parts of their electronic health data. In situations covered by the rule, restricted data are not normally displayed to the professional consulting the system, and the display must not reveal that hidden information exists. This protection matters for highly sensitive information.
There is, however, a clinical trade-off. If a patient hides a severe allergy, treatment or relevant condition, the clinician may make a decision without an essential piece of information. The Regulation requires people to be informed of the possible consequences of restrictions. The right to confidentiality should not be presented as a risk-free way to remove information from a clinical assessment.
In a serious emergency, the Regulation permits an exceptional access mechanism, sometimes called break the glass, to protect vital interests, subject to conditions and logging. This mechanism does not authorise curiosity or access to records without a medical reason. Member states may also establish stricter rules or opt-out options, and the details must be checked in national law.
Access logs: you will be able to see who opened your data and when
Article 9 provides for patients to be informed about access to their data through relevant services. The information must include the provider or person who accessed the data, the date and time, and the data consulted. The Regulation requires this information to remain available for at least three years after each access, subject to the law.
This means more than a page displaying an institution’s name: the log can make unusual access identifiable and help a patient ask questions or report a possible breach. A log is not, however, a guarantee that no error or incident will occur. Systems must be able to prevent, detect and investigate unjustified use, while authorities must enforce oversight.
In exceptional cases, notification or the display of certain information may be limited by applicable rules to protect vital interests or rights, under Article 9. It would therefore be wrong to promise that every country’s access log will look the same, or that every function is already available in Romania in 2026.
What opt-out rights exist: do not confuse care with research
EHDS involves two separate questions. The first is whether data can be shared through primary-use infrastructure for treatment. The second is whether they can be reused for research and other secondary purposes. These choices are not equivalent, and a choice on one does not automatically activate the choice on the other.
| Patient decision | European rule | Practical limit |
|---|---|---|
| Restricting certain data for care | A right provided by Article 8, with special exceptions in emergencies | The doctor may lose clinically important information |
| Complete opt-out from EHDS primary-use exchange | An option a member state may introduce by law, under Article 10 | It is not automatically available in every state and does not remove a hospital’s own documentation |
| Opting out of secondary use for research and other purposes | An opt-out right under Article 71 | It mainly applies to future authorisations; exceptional public-interest derogations exist |
| Correcting inaccurate information | A right to request rectification under EHDS and GDPR rules | It does not mean arbitrarily changing a diagnosis or deleting clinical history |
For secondary use, Article 71 creates a simple, reversible opt-out mechanism. A less widely explained detail is that opting out does not retroactively cancel research authorisations that have already been granted. If data were lawfully included in an analysis environment under an earlier permit, changing the preference does not automatically erase that use.
There are also limited exceptions: member states may, subject to strict safeguards and individual assessment, allow data to be used even after a person has opted out for certain major public-interest purposes, by authorised public entities and where the data cannot adequately be obtained otherwise. This is not a general loophole for private companies or marketing. These details are explained in the Commission’s guide to the reuse of health data.
Can a pharmaceutical company analyse the data, and can an employer request it?
The Regulation permits legitimate research and innovation projects under certain conditions, including projects involving the pharmaceutical industry and some technology providers. Access for secondary use is channelled through authorised bodies, approved purposes, data minimisation and secure environments. As a rule, anonymised data are used; pseudonymised data may be used only where anonymised data are insufficient. Pseudonymisation is not the same as full anonymisation, and attempts to re-identify people are prohibited.
Article 54 expressly prohibits uses including adverse decisions on employment, insurance or credit, advertising and marketing based on data obtained through the EHDS secondary-use mechanism. It would not be accurate to claim that “any pharmacy will see your diagnosis for personalised advertising”. There is no EHDS right to extract personal medical records in order to buy targeted advertising.
These prohibitions must nevertheless be stated precisely: they concern data accessed through the EHDS secondary-use mechanism. They do not automatically rewrite every rule in employment law, insurance, occupational medicine or medical documents voluntarily supplied in other settings. Assessing a particular case requires knowing who is requesting data, for what purpose, under which legal act and which GDPR rules apply.
How research data are protected: controlled access, not downloadable patient files
For reuse, researchers and eligible institutions must apply for a permit or approval provided for in the Regulation through a health data access body (HDAB). Processing takes place in secure environments, with access controls, logging and controls on extracted results. Article 73 addresses secure processing environments.
This is not a system in which a user enters a patient’s name into a search engine and downloads their tests. Protection has several layers: purpose limitation, removal of identifiers that are not needed, pseudonymisation where justified, controls on exportable data and a ban on re-identification. A statistical result about a group must not be turned into a commercial profile of an individual.
The potential benefits may be significant. In rare-disease research, combining data from several states can help produce larger samples and identify promising treatments. That is an objective and a potential benefit of the Regulation, not evidence that a particular new therapy had already been discovered because of EHDS by 2026.
Romania in 2026: what is currently available in eHealthaMea
CNAS announced the launch of the eHealthaMea portal on 1 September 2026. According to the official CNAS statement reproduced by AGERPRES, citizens access it through their ROeID digital identity after account verification and activation. Functions are being implemented in stages.
| CNAS service or information | What the institution said at launch | Interpretative limit |
|---|---|---|
| Insurance status and benefits package | Data visible after authentication | This does not automatically represent every clinical document |
| Electronic prescriptions | History of prescriptions issued in the previous five years | This does not prove that every prescription can already be dispensed at any pharmacy in the EU |
| Health history | History available for the previous 10 years | This does not guarantee that every private test or older document is in the portal |
| CNAS reimbursements | Services and amounts/points recorded in the system | Reimbursement is not the same as a detailed clinical result |
| Health card and insurance house | Card status, CID and insurance house | The physical card remains usable |
| Outpatient appointments | A list of providers enrolling for online appointments | Not every practice automatically offers appointments through the portal |
For readers seeking practical instructions on the Romanian platform and appointment availability, InfoBuz has already published an analysis of eHealthaMea and the limits of appointments in 2026. The focus here is the difference between today’s national access and EHDS rights that patients will gain in stages.
Important: the launch of eHealthaMea did not abolish Romania’s national health card or oblige all patients to create an account in order to receive consultations. CNAS explicitly stated that access to medical services is not conditional on registering on the portal. We do not recommend uploading personal documents to unofficial websites to “activate the European record”.
DES, eHealthaMea, MyHealth@EU and HealthData@EU: four names, distinct functions
| Name | Main role | Why they are not synonyms |
|---|---|---|
| DES — Electronic Health Record | A national system for storing and accessing medical data, regulated in Romania | It predates EHDS and has its own national rules |
| eHealthaMea | A CNAS portal providing information and access to available services and data | It is a national interface, with functions developed in stages |
| MyHealth@EU | A cross-border exchange infrastructure for patient care | It is not a research portal and does not mean general access for companies |
| HealthData@EU | A cooperation infrastructure for authorised secondary use | Research is subject to permits and conditions distinct from care |
Romania’s DES is governed, among other measures, by Ministry of Health/CNAS Order No. 1,123/849/2016, as amended. The system has rules on authentication, legal representation and access administration, while patients may request correction of certain errors under the relevant procedures and GDPR. The existence of DES does not mean that every clinic or hospital has fully supplied every medical document, or that all data are already interoperable between states.
There is another important point for citizens: EHDS does not require existing healthcare arrangements to be automatically replaced by a single European account. Authorities will have to develop compatible interfaces and mechanisms, while authentication practices, representation of minors and integration of national systems will depend on legal and technical implementation.
How a consultation in another country may work: a hypothetical example
Imagine a Romanian patient on holiday in Spain in 2030, after the EHDS’s 2029 stage. The patient seeks medical care and says they take chronic medication. A professional providing care, identified through approved mechanisms, may request through MyHealth@EU the patient summary and eligible prescription information. Available data are presented in an interoperable format, subject to applicable rules and restrictions.
This is an illustrative scenario, not a report of a Spanish service tested by the newsroom in 2026. Even at the 2029 stage, it should not automatically be assumed that all MRI images, laboratory results and discharge reports are available: obligations for that group are scheduled from 2031.
Because a professional may treat a patient in an emergency without access to the full record, an ordinary medical assessment, medical history and allergy checks remain important. Interoperability can assist clinical decisions, but it does not replace a conversation with the patient and verification of current medical information.
Who is responsible if a test result is wrong or missing from the record?
EHDS aims to improve access and interoperability, but it does not turn a laboratory error into a correct result. Patients will have rights to request rectification of information under the Regulation and GDPR. Rectification is not the same as deleting a clinical opinion with which a patient disagrees; mechanisms may exist to correct or supplement disputed information, and procedures depend on the facts and the law.
For missing data, the first step is to identify the institution that issued the document, its date and type, then check whether the information is in the system used by that institution and whether it falls within a category subject to exchange obligations. An empty screenshot does not prove that data were deleted or that a doctor failed to record them.
Where information is automatically presented through artificial-intelligence tools, patients should also distinguish original text from a generated summary. In another article, InfoBuz examined why an AI tool may help explain records without replacing medical interpretation.
Five transparency questions for Romania before March 2029
- Who is the designated digital-health institution, and what is the national contact point through which Romania will exchange data via MyHealth@EU?
- How will access logs, patient restrictions and the rectification procedure be presented in Romanian, including for people without digital skills?
- Which categories of documents will actually be interoperable in 2029, and what will remain for the 2031 stage?
- How will the opt-out right for secondary use be exercised in Romania, where will the interface appear, and what explanations will affected people receive?
- How will security and patient-identification errors be audited across DES, the CNAS portal, providers and national contact points?
These are editorial questions to follow during implementation, not claims that Romanian institutions have already refused to answer them. Public progress reporting should provide timelines, interoperability testing, security-audit results and accessibility documentation, rather than only announcements about a portal launch.
Practical guide: what a patient in Romania can do in 2026
- Check the source: use CNAS, clinic or hospital websites and European Commission pages; do not enter your CNP personal identification number, passwords or medical data on pages promising instant activation of an “EU record”.
- Consult information already available in Romania: use the CNAS eHealthaMea portal, based on functions available to your account and after ROeID authentication.
- Keep important medical documents: letters, results, allergy information and medication lists, especially before travelling, without assuming that cross-border exchange is universal before 2029.
- Ask for clarification about identification errors or missing documents: first from the issuing institution and, where appropriate, through DES, CNAS and GDPR procedures.
- Follow official EHDS updates: the 2029 deadline concerns the first data categories, while 2031 includes additional datasets.
- Do not confuse the options: the right to restrict data for treatment and the right to opt out of research are separate mechanisms with different effects.
For broader aspects of the national system, see InfoBuz’s analysis of CNAS, the health card, prescriptions and referrals in 2026–2027. This article is limited to EHDS rights, the timeline and responsibility for data access.
Frequently asked questions about the European health record
Will every EU doctor see my test results from 2027?
No. In 2027, part of the general and governance framework takes effect. The cross-border obligation for the first categories of health data — summaries, prescriptions and dispensing — begins on 26 March 2029. The stage for laboratory tests, imaging and discharge reports begins on 26 March 2031.
Will there be one centralised record in Brussels?
The Regulation establishes information exchange and interoperability among national systems through MyHealth@EU, not a public registry that lets anyone search by a patient’s name. Access remains controlled by roles and purposes.
Can I prevent a doctor from seeing sensitive information?
Article 8 provides for restrictions on parts of electronic health data under EHDS conditions, with possible exceptional access in critical situations involving vital interests. Restricting data may have medical consequences if the hidden information is relevant.
Can I see who has consulted my record?
Yes. The EHDS framework provides for an access log containing the institution or person, the time and the data consulted, retained in the access service for at least three years, subject to legal exceptions. Functions must be implemented in line with the applicable deadlines.
If I refuse reuse of my data for research, will they also be removed from earlier studies?
Not automatically. The opt-out for secondary use affects new permits and applications approved after the right is exercised; it does not retroactively cancel earlier authorisations. Strictly regulated exceptions also exist for certain public purposes.
Can an employer or insurer see my diagnoses through EHDS?
EHDS does not give employers and insurers a general right to consult records in order to make decisions on recruitment or premiums. Article 54 expressly prohibits using data obtained for secondary purposes in such adverse decisions. Other medical processing in separate legal contexts must be assessed independently.
Is the eHealthaMea portal already the European health record?
No. eHealthaMea is the national CNAS portal launched in September 2026. MyHealth@EU is the cross-border interoperability infrastructure, with exchange obligations introduced in stages from 2029 and 2031.
Do I need an eHealthaMea account to receive consultations in Romania?
No. CNAS said that the portal is a digital facility and that the national health card remains valid. Access to consultations is not conditional on creating a portal account.
Can a pharmaceutical company use EHDS data to develop treatments?
Yes, subject to the conditions for secondary use. Certain legitimate research may receive authorisation and use minimised, anonymised or pseudonymised data in secure environments. Freely downloading identifiable records or using them for individual marketing is not permitted.
Will all old test results appear immediately after 2031?
There is no such guarantee. The Regulation extends exchange to categories of results, and rights may also cover electronically processed historical data, but actual availability depends on the existence and quality of the data, systems integration and technical timelines.
Official sources and methodology
- Regulation (EU) 2025/327 — full EHDS text; Articles 3–15 (patient rights), 53–54 (permitted/prohibited purposes), 71 (opt-out), 73 (secure environment) and 105 (timeline).
- European Commission — official EHDS overview and timeline.
- European Commission — citizens’ rights over health data.
- European Commission — reuse of health data.
- Implementing Regulation (EU) 2026/2083 — operation of MyHealth@EU.
- Implementing Regulation (EU) 2026/2099 — exchange of professional identification information.
- CNAS official statement of 2 September 2026 — launch of the eHealthaMea portal, reproduced by AGERPRES.
- Ministry of Health/CNAS Order No. 1123/849/2016 — national framework for the Electronic Health Record.
InfoBuz editorial note — 14 November 2026: This article examines the EHDS legal framework and official European and Romanian communications available at the time of writing. We did not access personal medical records, test cross-border exchange with a real patient, or verify the operation of every national portal. The scenarios are hypothetical. Future rights are not presented as options already available to every person in Romania in 2026. This material does not replace individual legal advice or medical advice.







Discuția cititorilor
Ai o opinie sau o întrebare despre acest articol? Spune-ne ce crezi.
Fii primul care deschide discuția.
Te rugăm să păstrezi un limbaj civilizat și să discuți la subiect. Comentariile spam sunt filtrate automat.